Company intelligence / Profile preview

PharmBioTec

Schiffweiler, Saarland, Germany

Ownership: Private
Development stage: Other

Overview

PharmBioTec is a German Contract Research Organization (CRO) founded in 2010 as a non-profit spin-off of Saarland University. It specializes in pharmaceutical research and development, focusing on drug discovery, formulation, and analytics. A core mission is to develop new drugs and assays using modern in vitro methods to minimize animal testing (3R principles).

Modalities: Small moleculeIn vitro assays
Industry: Drug Discovery Services

Partnerships

Saarland UniversityHelmholtz Institute for Pharmaceutical Research Saarland (HIPS)Kaiserslautern University of Applied Sciences

Beyond the preview

Go deeper on PharmBioTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmBioTec.

Explore the full profile